Šalis: Jungtinės Valstijos
kalba: anglų
Šaltinis: NLM (National Library of Medicine)
ESOMEPRAZOLE MAGNESIUM (UNII: R6DXU4WAY9) (ESOMEPRAZOLE - UNII:N3PA6559FT)
NuCare Pharmaceuticals,Inc.
ORAL
PRESCRIPTION DRUG
Healing of Erosive Esophagitis Esomeprazole magnesium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole magnesium may be considered. Maintenance of Healing of Erosive Esophagitis Esomeprazole magnesium is indicated to maintain symptom resolution and healing of erosive esophagitis. Controlled studies do not extend beyond 6 months. Symptomatic Gastroesophageal Reflux Disease Esomeprazole magnesium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with GERD in adults and children 1 year or older. Esomeprazole magnesium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous NSAID therapy in patients at risk for developing gastric ulcers. Patients are considered to be at
Esomeprazole magnesium delayed-release capsules, USP 20 mg, are hard gelatin capsule shell, Dark blue opaque cap & body imprinted with ESO on cap and 20 on the body in golden yellow ink. They are supplied as follows: NDC 68071-4888-6 BOTTLES OF 60 Store at 25ºC (77ºF); excursions permitted to 15 to 30ºC (59 to 86ºF). [See USP Controlled Room Temperature]. Keep esomeprazole magnesium delayed-release capsules, USP container tightly closed. Dispense in a tight container if the esomeprazole magnesium delayed-release capsules, USP product package is subdivided.
Abbreviated New Drug Application
ESOMEPRAZOLE MAGNESIUM- ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE NuCare Pharmaceuticals,Inc. ---------- MEDICATION GUIDE Esomeprazole magnesium delayed-release capsules, USP (es ″ oh mep′ ra zole mag nee′ zee um) Read the Medication Guide that comes with esomeprazole magnesium delayed-release capsules, USP before you start taking esomeprazole magnesium delayed-release capsules, USP and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or your treatment. What is the most important information I should know about esomeprazole magnesium delayed-release capsules, USP? Esomeprazole magnesium delayed-release capsules may help your acid-related symptoms, but you could still have serious stomach problems. Talk with your doctor. Esomeprazole magnesium delayed-release capsules can cause serious side effects, including: · A type of kidney problem (acute interstitial nephritis). Some people who take proton pump inhibitor (PPI) medicines, including Esomeprazole magnesium, may develop a kidney problem called acute interstitial nephritis that can happen at any time during treatment with Esomeprazole magnesium. Call your doctor if you have a decrease in the amount that you urinate or if you have blood in your urine. • Diarrhea. Esomeprazole magnesium delayed-release capsules may increase your risk of getting severe diarrhea. This diarrhea may be caused by an infection (Clostridium difficile) in your intestines. Call your doctor right away if you have watery stool, stomach pain, and fever that does not go away. • Bone fractures. People who take multiple daily doses of Proton Pump Inhibitor medicines for a long period of time (a year or longer) may have an increased risk of fractures of the hip, wrist, or spine. You should take esomeprazole magnesium delayed-release capsules exactly as prescribed, at the lowest dose possible for your treatment and for the shortest time needed. Talk to your doctor about your r Perskaitykite visą dokumentą
ESOMEPRAZOLE MAGNESIUM- ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE NUCARE PHARMACEUTICALS,INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES. ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1989 (OMEPRAZOLE) RECENT MAJOR CHANGES Warnings and Precautions, Fundic Gland Polyps (5.12) 06/2018 INDICATIONS AND USAGE Esomeprazole magnesium delayed-release capsules, USP is a proton pump inhibitor indicated for the following: • Treatment of gastroesophageal reflux disease (GERD) ( 1.1) • Risk reduction of NSAID-associated gastric ulcer ( 1.2) _• H. pylori _eradication to reduce the risk of duodenal ulcer recurrence ( 1.3) • Pathological hypersecretory conditions, including Zollinger-Ellison syndrome ( 1.4) DOSAGE AND ADMINISTRATION INDICATION DOSE FREQUENCY GASTROESOPHAGEAL REFLUX DISEASE (GERD) Adults 20 mg or 40 mg Once daily for 4 to 8 weeks 12 to 17 years 20 mg or 40 mg Once daily for up to 8 weeks 1 to 11 years 10 mg or 20 mg Once daily for up to 8 weeks RISK REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER 20 mg or 40 mg Once daily for up to 6 months H.PYLORI ERADICATION (TRIPLE THERAPY): Esomeprazole magnesium 40 mg Once daily for 10 days Amoxicillin 1000 mg Twice daily for 10 days Clarithromycin 500 mg Twice daily for 10 days PATHOLOGICAL HYPERSECRETORY CONDITIONS 40 mg Twice daily See full prescribing information for administration options ( 2) Patients with severe liver impairment-do not exceed dose of 20 mg( 2) DOSAGE FORMS AND STRENGTHS Esomeprazole magnesium delayed-release capsules, USP: 20 mg and 40 mg ( 3) CONTRAINDICATIONS Patients with known hypersensitivity to proton pump inhibitors (PPIs) (angioedema and anaphylaxis have occurred) ( 4) WARNINGS AND PRECAUTIONS Gastric Malignancy: In adults, symptomatic response does not preclude the pre Perskaitykite visą dokumentą